Johnson & Johnson (JNJ)
209.72
+5.33
(+2.61%)
USD |
NYSE |
Jan 12, 16:00
210.04
+0.32
(+0.15%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 505.28B for Jan. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 175.30B |
| Gilead Sciences, Inc. | 152.11B |
| Eli Lilly & Co. | 967.52B |
| Regeneron Pharmaceuticals, Inc. | 80.72B |
| Protagonist Therapeutics, Inc. | 5.017B |
Market Cap Related Metrics
| PE Ratio | 20.24 |
| PS Ratio | 5.518 |
| PEG Ratio | 0.2839 |
| Price to Book Value | 6.374 |
| Price to Free Cash Flow | 24.85 |
| Price | 209.72 |
| Earnings Yield | 4.94% |
| PEGY Ratio | 0.2745 |
| Operating PE Ratio | 21.40 |
| Normalized PE Ratio | 24.60 |